OrthoDirectUSA website
How A Facility Implements Generic Orthopedic Implants
This article is written by Blair Rhode, MD.
The acceptance and implementation of generics into the field of orthopedics has been a slow process. This is because it requires significant internal change in behavior and who likes change?
Generic Implants are all about change management. Tommy Mitchell, CEO of OrthoDirectUSA, consults with hospitals (providers) that desire to purchase generic implants and manage these devices independent of sales rep involvement. He says, "The need for a change management process just to accurately define the problem is the first chasm providers must cross. While the motivation to consider generics is growing rapidly, often by time the provider finally completes the business case, calculating the Net Acquisition Savings Analysis, the whole idea gets stalled and the motivation is lost."
Step 1 is to define the problem:
1. We all know that implants cost too much. They consume as much as 50 percent of the DRG for a total knee replacement. We know that most of this technology is expired IP and deserves to be a value based, generic offering. The hospital desires to purchase...
